SCHEMBL4845228

SCHEMBL4845228

O=C(O)c1cccc(CCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cccc(C(F)(F)F)c3)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.41
ADAMTS7 Q9UKP4 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
MMP8 P22894 2/20 0.40
MMP3 P08254 1/20 0.40
NAMPT P43490 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
CDK8 P49336 1/20 0.38
LMNA P02545 1/20 0.38
TRPA1 O75762 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842635 0.93 RORC (0.42) RORCADAMTS7ADAMTS5MMP8MMP3
SCHEMBL4841534 0.92 LIPG (0.45) RORCADAMTS7ADAMTS5MMP8MMP3
SCHEMBL4837253 0.92 RORC (0.41) RORCADAMTS7ADAMTS5MMP8NAMPT
SCHEMBL4845363 0.91 RORC (0.43) RORCMMP8MMP3PSEN1PSEN2
SCHEMBL4842556 0.89 RORC (0.43) RORCMMP8MMP3CA12CA1
SCHEMBL4842554 0.89 RORC (0.43) RORCMMP8MMP3CA12CA1
SCHEMBL4211574 0.88 MMP8 (0.41) RORCMMP8MMP3MEN1KMT2A
SCHEMBL4840605 0.87 RORC (0.44) RORCADAMTS7ADAMTS5MMP8MMP3
SCHEMBL3827372 0.87 RORC (0.46) RORCMMP8MMP3KMT2ATRPA1
SCHEMBL4039810 0.87 MEN1 (0.51) RORCNAMPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885ADAMTS7 4538/4885ADAMTS5 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.